Cannabis Use and Mental Health: A Critical Analysis of Current Research
DOI:
https://doi.org/10.12775/QS.2025.39.59154Keywords
mentahl health, cannabis, psychosis, schizophrenia, depression, cognitive functionsAbstract
Cannabis is one of the most widely used psychoactive substances globally. In several countries, including Canada, the Netherlands, certain U.S. states, and Australia, its possession is legal. With its growing popularity in recent years, the impact of cannabis on mental health has become a focal point of numerous scientific studies. The aim of this review was to summarize the current evidence-based knowledge on the impact of cannabis on mental health. This article explores the relationship between cannabis use and specific mental disorders. The reviewed literature was sourced from PubMed and Google Scholar using the keywords "mental health", "cannabis", "psychosis" "schizophrenia" "depression" and "cognitive functions".
References
1. Sharma P., Murthy P., Bharath M. M. Chemistry, metabolism and toxicology of cannabis: Clinical implications. Iran J Psychiatry. 2012;7:149-156. PMID: 23408483; PMCID: PMC3570572.
2. United Nations Office on Drugs and Crime. (2013). World drug report 2013. United Nations Publications. https://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdf
3. Krajowe Biuro do Spraw Przeciwdziałania Narkomanii. (2019). Report on the state of drug addiction in Poland 2019. https://ore.edu.pl/wp-content/uploads/2020/02/raport-o-stanie-narkomanii-w-polsce-2019.pdf (Original work in Polish)
4. Oberbarnscheidt T., Miller N. Pharmacology of marijuana. J Addict Res Ther. 2017;S11. https://doi.org/10.4172/2155-6105.s11-012.
5. Hua T., Li X., Wu L., et al. Activation and signaling mechanism revealed by cannabinoid receptor-Gi complex structures. Cell. 2020;180(4):655-665.e18. https://doi.org/10.1016/j.cell.2020.01.008.
6. Sharma R., Shah A. Cannabis-induced psychosis masquerading schizophrenia or vice-versa? A diagnostic dilemma. Ind Psychiatry J. 2021 Oct. https://doi.org/10.4103/0972-6748.328842.
7. D’Souza D. C., Perry E., MacDougall L., Ammerman Y., Cooper T., Wu Y. T., et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology. 2004;29:1558-1572. https://doi.org/10.1038/sj.npp.1300496
8. West M. L., Sharif S. Cannabis and psychosis. Psychiatric Clinics of North America. 2023 Dec;46(4):703-717. https://doi.org/10.1016/j.psc.2023.03.006
9. Kelley M. E., Wan C. R., Broussard B., Crisafio A., Cristofaro S., Johnson S., Reed T. A., Amar P., Kaslow N. J., Walker E. F. Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders. Schizophrenia Research. 2016;171:62–67. https://doi.org/10.1016/j.schres.2016.01.015
10. Kuepper R., van Os J., Lieb R., et al. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10-year follow-up cohort study. BMJ. 2011;342:d738. PMCID: PMC3047001 https://doi.org/10.1136/bmj.d738
11. Freeman T. P., Craft S., Wilson J., et al. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: Systematic review and meta-analysis. Addiction. 2021;116:1000-1010. https://doi.org/10.1111/add.15253
12. Di Forti M., Quattrone D., Freeman T. P. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): A multicentre case-control study. Lancet Psychiatry. 2019;6:427–436. https://doi.org/10.1016/S2215-0366(19)30048-3
.
13. Van der Steur S. J., Batalla A., Bossong M. G. Factors moderating the association between cannabis use and psychosis risk: A systematic review. PMID: 32059350.
14. Hall W., Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374(9698):1383–1391. https://doi.org/10.1016/S0140-6736(09)61037-0.
15. Vaucher, J., Keating, B., Lasserre, A. et al. Cannabis use and risk of schizophrenia: a Mendelian randomization study. Mol Psychiatry 23, 1287–1292 (2018). https://doi.org/10.1038/mp.2016.252
16. Gage, S. H., Hickman, M., & Zammit, S. (2016). Association between cannabis and psychosis: Epidemiologic evidence. Biological Psychiatry, 79(7), 549–556. https://doi.org/10.1016/j.biopsych.2015.06.022
17. Large, M., Di Forti, M., & Murray, R. (2015). Cannabis: Debated schizophrenia link. Nature, 527(7577), 305. https://doi.org/10.1038/527305a
18. Andréasson S., Engström A., Allebeck P., Rydberg U. Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. The Lancet. 1987;330:1483–1486. https://doi.org/10.1016/s0140-6736(87)92620-1
19. Urits I., Gress K., Charipova K., et al. Cannabis use and its association with psychological disorders. Psychopharmacol Bull. 2020 May 19;50(2):56–67. PMID: 32508368.
20. Lowe D. J. E., Sasiadek J. D., Coles A. S., George T. P. Cannabis and mental illness: A review. Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):107-120. https://doi.org/10.1007/s00406-018-0970-7.
21. Bhatt B., Naik Nagappa A., Patil C. R. Role of oxidative stress in depression. Drug Discovery Today. 2020;25(7):1270-1276. https://doi.org/10.1016/j.drudis.2020.05.001.
22. Hengartner M. P., Angst J., Ajdacic-Gross V., Rössler W. Cannabis use during adolescence and the occurrence of depression, suicidality, and anxiety disorder across adulthood: Findings from a longitudinal cohort study over 30 years. J Affect Disord. 2020 Jul 1;272:98-103. https://doi.org/10.1016/j.jad.2020.03.126.
23. Onaemo V. N., Fawehinmi T. O., D'Arcy C. Comorbid cannabis use disorder with major depression and generalized anxiety disorder: A systematic review with meta-analysis of nationally representative epidemiological surveys. J Affect Disord. 2021 Feb 15;281:467-475. https://doi.org/10.1016/j.jad.2020.12.043.
24. Gobbi G., Atkin T., Zytynski T., et al. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: A systematic review and meta-analysis. JAMA Psychiatry. 2019;76(4):426-434. https://doi.org/10.1001/jamapsychiatry.2018.4500.
25. Hill K. P., Gold M. S., Nemeroff C. B., McDonald W., Grzenda A., Widge A. S., Rodriguez C., Kraguljac N. V., Krystal J. H., Carpenter L. L. Risks and benefits of cannabis and cannabinoids in psychiatry. Am J Psychiatry. 2022 Feb;179(2):98-109. https://doi.org/10.1176/appi.ajp.2021.21030320.
26. Zehra A., Burns J., Liu C. K., Manza P., Wiers C. E., Volkow N. D., Wang G. J. Cannabis addiction and the brain: A review. J Neuroimmune Pharmacol. 2018 Dec;13(4):438-452. https://doi.org/10.1007/s11481-018-9782-9.
27. Hall W., Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009 Oct 17;374(9698):1383-1391. https://doi.org/10.1016/S0140-6736(09)61037-0.
28. Meier, M. H., Caspi, A., Knodt, A. R., Hall, W., Ambler, A., Harrington, H., Hogan, S., Houts, R. M., Poulton, R., Ramrakha, S., Hariri, A. R., & Moffitt, T. E. (2022). Long-term cannabis use and cognitive reserves and hippocampal volume in midlife. American Journal of Psychiatry, 179(5), 362-374. https://doi.org/10.1176/appi.ajp.2021.21060664
29. Scott J. C., Cobb J. R. Impact of adolescent cannabis use on neurocognitive and brain development. Psychiatric Clinics of North America. 2023 Dec;46(4):655-676. https://doi.org/10.1016/j.psc.2023.03.012.
30. Maggirwar S. B., Khalsa J. H. The link between cannabis use, immune system, and viral infections. Viruses. 2021 Jun 9;13(6):1099. https://doi.org/10.3390/v13061099.
31. Meah F., Lundholm M., Emanuele N., Amjed H., Poku C., Agrawal L., Emanuele M. A. The effects of cannabis and cannabinoids on the endocrine system. Reviews in Endocrine and Metabolic Disorders. 2022 Jun;23(3):401-420. https://doi.org/10.1007/s11154-021-09682-w. Epub 2021 Aug 30.
32. Bespalova N., Bunt G., Hill K. P. Cannabis and pregnancy. Current Psychiatry Reports. 2024 Nov;26(11):643-649. https://doi.org/10.1007/s11920-024-01536-x.
33. Support for Legal Marijuana Inches Up to New High of 68%, Gallup Inc., 2020, https://news.gallup.com/poll/323582/support-legal-marijuana-inches-new-high.aspx
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Kacper Rusiński, Filip Klimas, Dorota Zatłoka-Mazur, Zuzanna Zięba, Adriana Potoczek , Iwona Pudełko , Izabela Kazubek-Fuksiewicz, Klaudia Ostrowicz, Izabela Lekan

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 148
Number of citations: 0